
After missing the entire 2024 season because of an elbow injury, Lucas Giolito will start the 2025 season on the IL because of a strained left hamstring. Gerald Herbert/Associated Press
The Boston Red Sox will open the season with three starting pitchers on the injured list after right-hander Lucas Giolito strained his left hamstring.
Giolito left his first spring training start against Philadelphia on Tuesday after one inning when his hamstring tightened. Giolito told reporters the strain was low-grade.
Red Sox manager Alex Cora said the right-hander will start the season on the injured list.
Giolito will join fellow starters Brayan Bello (shoulder) and Kutter Crawford (knee) on the injured list ahead of Boston’s March 27 opener at Texas.
Giolito, 30, signed a $38.5 million, two-year contract with Boston before last season, but didn’t pitch all year after a partial tear in his right ulnar collateral ligament. He was 8-15 with a 4.88 ERA in 2023 with the Chicago White Sox, Los Angeles Angels and Cleveland Guardians.
DAVID HAMILTON went 2 for 4 with a solo home run in the first inning, and Romy Gonzalez scored on an error in the top of the eighth as the Red Sox beat the Mets, 3-2, in a spring training game in Port St. Lucie, Florida.
Abraham Toro added an RBI double. Gonzalez had two hits, including a double.
Send questions/comments to the editors.
We invite you to add your comments. We encourage a thoughtful exchange of ideas and information on this website. By joining the conversation, you are agreeing to our commenting policy and terms of use. More information is found on our FAQs. You can modify your screen name here.
Comments are managed by our staff during regular business hours Monday through Friday as well as limited hours on Saturday and Sunday. Comments held for moderation outside of those hours may take longer to approve.
Join the Conversation
Please sign into your Press Herald account to participate in conversations below. If you do not have an account, you can register or subscribe. Questions? Please see our FAQs.